Abiopharma

Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025

Dentsply Sirona Reports Third Quarter 2025 Results

Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025

UroGen Reports 77.8% Three-Month Complete Response Rate from Phase 3 UTOPIA Trial of UGN-103 and Receives FDA Agreement on NDA Submission Strategy in Recurrent LG-IR-NMIBC Based on UTOPIA Trial

Vericel Reports Third Quarter 2025 Financial Results

Cronos Group Reports 2025 Third Quarter Results

Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance